To date, more than 6,500 patients have been treated with CARVYKTI ®, the first and only CAR T-cell treatment in multiple myeloma to show overall survival benefit vs. standard of care. In a subset ...

Europe sees about 50,000 new cases of multiple myeloma annually, with most patients eventually relapsing from initial treatments. Blenrep, an anti-BCMA (B-cell maturation antigen) antibody-drug ...

Multiple myeloma is considered incurable, but a third of patients in a Johnson & Johnson clinical trial have lived without detectable cancer for years after facing certain death. By Gina Kolata A ...

"No therapies currently approved for the treatment of triple-class exposed/refractory [multiple myeloma] achieve similar ... and median bone marrow plasma cells (5% vs 24%).

People with osteopenia, the official name for low bone density, are at much greater risk of fractures than people with healthy bones. Loss of bone mass disproportionately affects aging women ...

Estrogen serves as the primary guardian of bone health in women throughout their reproductive years. This hormone plays multiple crucial ... balance necessary for healthy bone remodeling ...

Your bone marrow is supposed to be your body’s reliable blood cell factory, churning out healthy red cells ... Treating AML is like waging war on multiple fronts simultaneously.